reference/12678259

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12678259

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	510
issn	0160-2446
issueIdentifier	5
pageRange	506-510
publicationName	Journal of Cardiovascular Pharmacology
startingPage	506
bibliographicCitation	Ogimoto A, Okayama H, Nagai T, Ohtsuka T, Suzuki J, Inoue K, Nishimura K, Saito M, Shigematsu Y, Hamada M, Miki T, Higaki J. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy. J Cardiovasc Pharmacol. 2010 May;55(5):506–10. doi: 10.1097/fjc.0b013e3181d8bc4b. PMID: 20179607.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44ac1a8fb541e0cca09c5fd9711ce7f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac5b2751a12a45f9e7c809c5fda40366 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ffbd6d65879b1ea5c0b19583f164239 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b79ec2c3f2413f9290fbf06accfdbb69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e372408765619922c98a843a5c6c3499 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f23754c0b0611403b7435d41d059ff9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e9f8efaf9d2d11968d8c9f18ae2705c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc920ee417f8dd3003827d5496b4806c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb25f4ac971b157a98ae7a82f423986b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcc1689cafe66587f2ae019caa913c9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb31b8f7ad25e369a8baafce2324d050 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0328c15efe189696f2e2693eb81d744d
date	201005
identifier	https://doi.org/10.1097/fjc.0b013e3181d8bc4b https://pubmed.ncbi.nlm.nih.gov/20179607
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5285 https://portal.issn.org/resource/ISSN/0160-2446
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pharmacogenetic Interactions Between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Response to Cibenzoline in Patients With Hypertrophic Obstructive Cardiomyopathy
discusses	http://id.nlm.nih.gov/mesh/M0012049 http://id.nlm.nih.gov/mesh/M0006644 http://id.nlm.nih.gov/mesh/M0100508 http://id.nlm.nih.gov/mesh/M0001326 http://id.nlm.nih.gov/mesh/M0011048
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D017353 http://id.nlm.nih.gov/mesh/D000889Q000627 http://id.nlm.nih.gov/mesh/D007703Q000235 http://id.nlm.nih.gov/mesh/D016254 http://id.nlm.nih.gov/mesh/D002312Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016277Q000187 http://id.nlm.nih.gov/mesh/D002312Q000000981 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D007093Q000008 http://id.nlm.nih.gov/mesh/D002312Q000503 http://id.nlm.nih.gov/mesh/D000889Q000097 http://id.nlm.nih.gov/mesh/D002312Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007093Q000097 http://id.nlm.nih.gov/mesh/D000889Q000008 http://id.nlm.nih.gov/mesh/D005787 http://id.nlm.nih.gov/mesh/D010597 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004247Q000235 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004452
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2747 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7179

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1636 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128201811

Total number of triples: 65.